VySpine Gains FDA 510(k) for LumiVy Lumbar IBF with NanoVy Ti

VySpine received FDA 510(k) clearance to market its LumiVy NanoVy Ti Lumbar IBF System, indicated for intervertebral body fusion at either one level or two contiguous levels in the lumbar spine for the treatment of degenerative disc disease with up to Grade 1 spondylolisthesis.

The LumiVy NanoVy Ti Lumbar IBF System features VySpine's NanoVy...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

  • This field is for validation purposes and should be left unchanged.

0